Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ardelyx, Inc. - Common Stock
(NQ:
ARDX
)
3.090
+0.080 (+2.66%)
Delayed Quote
Updated: 12:13 PM EST, Nov 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ardelyx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Ardelyx, Inc. (NASDAQ: ARDX) is November 16, 2026
Today 6:45 EST
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities Lawsuit - Contact SueWallSt
November 10, 2026
Notice to pension funds, asset managers, and fiduciaries: the lawsuit contends Ardelyx maintained its long-term revenue outlook for XPHOZAH and IBSRELA while payer access barriers were allegedly...
From
SueWallSt
Via
GlobeNewswire
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
November 10, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
November 09, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact Levi & Korsinsky
November 09, 2026
Regulatory Compliance Focus: The lawsuit contends Ardelyx assured the market it had confidently addressed a shifting Medicare reimbursement environment for XPHOZAH and IBSRELA, while payer...
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
November 06, 2026
From
Levi & Korsinsky, LLP
Via
ACCESS Newswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
November 05, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Kaplan Fox Deadline Alert: Ardelyx, Inc. (NASDAQ: ARDX) Investors Have Until November 16, 2026 to Seek a Lead Plaintiff Role
November 04, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
November 03, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
November 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
November 03, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDX UPCOMING DEADLINE: SueWallSt Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm
November 03, 2026
Time-Sensitive: Allegations focus on Ardelyx's representations that its patient-access strategy was working, while more stringent prior authorization and step edit requirements were allegedly slowing...
From
SueWallSt
Via
GlobeNewswire
Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation
November 03, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
November 02, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
November 02, 2026
Promise vs. Reality: Ardelyx pointed investors toward $1.75 billion in combined peak sales for IBSRELA and XPHOZAH, while the complaint alleges payer utilization-management barriers were already...
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
ARDELYX DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
October 31, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline
October 30, 2026
From
Levi & Korsinsky, LLP
Via
ACCESS Newswire
Kaplan Fox Urges Ardelyx, Inc. (NASDAQ: ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026
October 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
October 27, 2026
From
Pomerantz LLP
Via
GlobeNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX
October 27, 2026
Ardelyx's Chief Commercial Officer, Eric Foster, is named as an individual defendant in a securities class action alleging he assured investors the Company's patient-access strategy was working while...
From
SueWallSt
Via
GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 27, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
ARDX Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Ardelyx, Inc. Class Action Lawsuit
October 26, 2026
San Diego, California--(Newsfile Corp. - October 26, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or...
Via
Newsfile
Topics
Lawsuit
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026 - ARDX
October 26, 2026
Ardelyx's chief executive, two successive chief financial officers, and its chief commercial officer are each named as individual defendants in a securities class action alleging they controlled public...
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate Binders
October 23, 2026
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 23, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX
October 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026
October 20, 2026
A securities class action chronicles how Ardelyx allegedly reaffirmed billion-dollar sales targets for IBSRELA and XPHOZAH across 19 months while payer prior authorization and step edit barriers were...
From
SueWallSt
Via
GlobeNewswire
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
October 20, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026
October 20, 2026
Conference call scheduled for 4:30 p.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class Action - Contact the Firm
October 19, 2026
Time-Sensitive: Allegations focus on Ardelyx's representations that its patient-access strategy was working, while more stringent prior authorization and step edit requirements were allegedly slowing...
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
